Aromasin 10 - Unique Pharma

Exemestane, a steroidal aromatase inhibitor, was first approved by the FDA in 1999 for the treatment of estrogen-sensitive breast cancer. Sold under the brand Aromasin, it works by irreversibly binding to the aromatase enzyme, reducing estrogen levels by 85%. In bodybuilding, it is used off-label to mitigate estrogenic side effects from anabolic steroid use, including gynecomastia and water retention. Its potent anti-estrogenic effects make it a preferred choice for athletes seeking a lean, defined look while minimizing estrogen-related fat gain .

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Aromasin 10 by Unique Pharma, consult with your doctor or healthcare professional.